1 Market Overview
1.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Surgical Treatment
1.2.3 Minimally Invasive Treatment
1.2.4 Laser Treatment
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Fertility Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Overview of Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market
1.4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Benign Prostatic Hyperplasia (BPH) Treatment Devices Industry Impact
1.6.1 COVID-19 Potential Implications for the Benign Prostatic Hyperplasia (BPH) Treatment Devices
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Benign Prostatic Hyperplasia (BPH) Treatment Devices
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Advin Urology
2.1.1 Advin Urology Details
2.1.2 Advin Urology Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Advin Urology SWOT Analysis
2.1.4 Advin Urology Product and Services
2.1.5 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 JenaSurgical GmbH
2.2.1 JenaSurgical GmbH Details
2.2.2 JenaSurgical GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 JenaSurgical GmbH SWOT Analysis
2.2.4 JenaSurgical GmbH Product and Services
2.2.5 JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 CONMED
2.3.1 CONMED Details
2.3.2 CONMED Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 CONMED SWOT Analysis
2.3.4 CONMED Product and Services
2.3.5 CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Biolitec
2.4.1 Biolitec Details
2.4.2 Biolitec Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Biolitec SWOT Analysis
2.4.4 Biolitec Product and Services
2.4.5 Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 HistoSonics, Inc.
2.5.1 HistoSonics, Inc. Details
2.5.2 HistoSonics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 HistoSonics, Inc. SWOT Analysis
2.5.4 HistoSonics, Inc. Product and Services
2.5.5 HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boston Scientific Corporation
2.6.1 Boston Scientific Corporation Details
2.6.2 Boston Scientific Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Boston Scientific Corporation SWOT Analysis
2.6.4 Boston Scientific Corporation Product and Services
2.6.5 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 LISA Laser Products GmbH
2.7.1 LISA Laser Products GmbH Details
2.7.2 LISA Laser Products GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 LISA Laser Products GmbH SWOT Analysis
2.7.4 LISA Laser Products GmbH Product and Services
2.7.5 LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 CoreTherm Medical, Inc. (ProstaLund)
2.8.1 CoreTherm Medical, Inc. (ProstaLund) Details
2.8.2 CoreTherm Medical, Inc. (ProstaLund) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 CoreTherm Medical, Inc. (ProstaLund) SWOT Analysis
2.8.4 CoreTherm Medical, Inc. (ProstaLund) Product and Services
2.8.5 CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Convergent Laser Technologies
2.9.1 Convergent Laser Technologies Details
2.9.2 Convergent Laser Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Convergent Laser Technologies SWOT Analysis
2.9.4 Convergent Laser Technologies Product and Services
2.9.5 Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 KARL STORZ
2.10.1 KARL STORZ Details
2.10.2 KARL STORZ Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 KARL STORZ SWOT Analysis
2.10.4 KARL STORZ Product and Services
2.10.5 KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Siemens
2.11.1 Siemens Details
2.11.2 Siemens Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Siemens SWOT Analysis
2.11.4 Siemens Product and Services
2.11.5 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 NeoTract
2.12.1 NeoTract Details
2.12.2 NeoTract Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 NeoTract SWOT Analysis
2.12.4 NeoTract Product and Services
2.12.5 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Lumenis Ltd.
2.13.1 Lumenis Ltd. Details
2.13.2 Lumenis Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Lumenis Ltd. SWOT Analysis
2.13.4 Lumenis Ltd. Product and Services
2.13.5 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Baxter International
2.14.1 Baxter International Details
2.14.2 Baxter International Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Baxter International SWOT Analysis
2.14.4 Baxter International Product and Services
2.14.5 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Olympus
2.15.1 Olympus Details
2.15.2 Olympus Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Olympus SWOT Analysis
2.15.4 Olympus Product and Services
2.15.5 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Medtronic
2.16.1 Medtronic Details
2.16.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Medtronic SWOT Analysis
2.16.4 Medtronic Product and Services
2.16.5 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Medifocus, Inc.
2.17.1 Medifocus, Inc. Details
2.17.2 Medifocus, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Medifocus, Inc. SWOT Analysis
2.17.4 Medifocus, Inc. Product and Services
2.17.5 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Urotech
2.18.1 Urotech Details
2.18.2 Urotech Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Urotech SWOT Analysis
2.18.4 Urotech Product and Services
2.18.5 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Urologix
2.19.1 Urologix Details
2.19.2 Urologix Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Urologix SWOT Analysis
2.19.4 Urologix Product and Services
2.19.5 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Endo International
2.20.1 Endo International Details
2.20.2 Endo International Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Endo International SWOT Analysis
2.20.4 Endo International Product and Services
2.20.5 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturer Market Share in 2019
3.3.2 Top 6 Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Regions (2015-2020)
4.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Regions (2015-2020)
4.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
4.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
4.5 South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Market Share by Country
5.1.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Country (2015-2020)
5.1.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Country (2015-2020)
5.2 United States Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
5.3 Canada Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
5.4 Mexico Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Market Share by Country
6.1.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Country (2015-2020)
6.1.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Country (2015-2020)
6.2 Germany Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
6.3 UK Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
6.4 France Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
6.5 Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
6.6 Italy Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Regions (2015-2020)
7.2 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
7.3 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
7.4 Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
7.5 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
7.7 Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Market Share by Country
8.1.1 South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Country (2015-2020)
8.1.2 South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Country (2015-2020)
8.2 Brazil Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
8.3 Argentina Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
9.3 Turkey Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
9.4 Egypt Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
9.5 South Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Type (2015-2020)
10.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Type (2015-2020)
10.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Type (2015-2020)
11 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Segment by Application
11.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2015-2020)
11.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Application (2015-2020)
11.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Application (2015-2020)
12 Market Forecast
12.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Growth Rate (2021-2025)
12.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast by Regions (2021-2025)
12.2.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast (2021-2025)
12.2.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast (2021-2025)
12.2.3 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast (2021-2025)
12.2.4 South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast (2021-2025)
12.2.5 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast (2021-2025)
12.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast by Type (2021-2025)
12.3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Type (2021-2025)
12.3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share Forecast by Type (2021-2025)
12.4 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast by Application (2021-2025)
12.4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Application (2021-2025)
12.4.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
【掲載企業】
Advin Urology、JenaSurgical GmbH、CONMED、Biolitec、HistoSonics, Inc.、Boston Scientific Corporation、LISA Laser Products GmbH、CoreTherm Medical, Inc. (ProstaLund)、Convergent Laser Technologies、KARL STORZ、Siemens、NeoTract、Lumenis Ltd.、Baxter International、Olympus、Medtronic、Medifocus, Inc.、Urotech、Urologix、Endo International
【免責事項】
https://www.globalresearch.jp/disclaimer